Brief: Impel Pharmaceuticals Chief Financial & Business Officer Resigns

IPI Legacy Liquidation Co

03/03/2023 22:17

March 3 (Reuters) - Impel Pharmaceuticals Inc  IMPL.O :
    * IMPEL PHARMACEUTICALS - ON FEB 27 JOHN LEAMAN GAVE NOTICE
OF
RESIGNATION FROM POSITION AS CHIEF FINANCIAL & BUSINESS OFFICER
EFFECTIVE MARCH 10, 2023
    * IMPEL PHARMACEUTICALS - ON MARCH 2, 2023, RAJIV AMIN WAS
APPOINTED TO SERVE AS INTERIM CHIEF FINANCIAL OFFICER, EFFECTIVE
MARCH 10, 2023

Source: (shorturl.at/dqsOU)
Further company coverage:  IMPL.O 

 ((Reuters.Briefs@thomsonreuters.com;))